Skip to content

Alessandro Gozzi

4 papers in the library · publishing 2008-2022

Papers

Sort Most recent Most cited

Unique spatiotemporal fMRI dynamics in the awake mouse brain.

Current Biology February 7, 2022 Daniel Gutierrez-Barragan, Neha Atulkumar Singh, Filomena Grazia Alvino et al.

Human imaging studies have shown that spontaneous brain activity exhibits stereotypic spatiotemporal reorganization in awake, conscious conditions with respect to minimally conscious states. However, whether and how this phenomenon can be generalized to lower mammalian species remains unclear. Leveraging a robust protocol for resting-state fMRI (rsfMRI) mapping in non-anesthetized, head-fixed...

Regional, Layer, and Cell-Type-Specific Connectivity of the Mouse Default Mode Network

Neuron December 1, 2020 Jennifer D. Whitesell, Adam Liska, Ludovico Coletta et al.

Summary The evolutionarily conserved default mode network (DMN) is a distributed set of brain regions coactivated during resting states that is vulnerable to brain disorders. How disease affects the DMN is unknown, but detailed anatomical descriptions could provide clues. Mice offer an opportunity to investigate structural connectivity of the DMN across spatial scales with cell-type resolution....

The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia.

Journal of Pharmacology and Experimental Therapeutics July 2011 Charles H Large, Silvia Bison, Ilaria Sartori et al.

Sodium channel inhibition is a well precedented mechanism used to treat epilepsy and other hyperexcitability disorders. The established sodium channel blocker and broad-spectrum anticonvulsant lamotrigine is also effective in the treatment of bipolar disorder and has been evaluated in patients with schizophrenia. Double-blind placebo-controlled clinical trials found that the drug has potential...

Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat.

Psychopharmacology December 1, 2008 Alessandro Gozzi, Hugh Herdon, Adam Schwarz et al.

Increasing experimental evidence suggests that impaired N-methyl-D: -aspartic acid (NMDA) receptor (NMDAr) function could be a key pathophysiological determinant of schizophrenia. Agonists at the allosteric glycine (Gly) binding site of the NMDA complex can promote NMDAr activity, a strategy that could provide therapeutic efficacy for the disorder. NMDAr antagonists like phencyclidine (PCP) can...